Department of Pediatrics, Tohoku University Graduate School of Medicine.
Department of General Pediatrics, Miyagi Children's Hospital, Miyagi.
J Pediatr Gastroenterol Nutr. 2020 Sep;71(3):333-339. doi: 10.1097/MPG.0000000000002796.
Causes of early-onset refractory diarrhea include exudative diarrhea associated with very early-onset inflammatory bowel diseases, osmotic or secretory diarrhea, and protein-losing enteropathy. Monogenic disorders are included in these diseases, yet a comprehensive genetic analysis has not been fully established.
We established targeted gene panels covering all responsible genes for early-onset diarrhea. In total, 108 patients from 15 institutions were enrolled in this study. We collected clinical data from all patients. Seventy-three patients with exudative diarrhea, 4 with osmotic or secretory diarrhea and 8 with protein-losing enteropathy were subjected to genetic analysis.
A total of 15 out of the 108 enrolled patients (13.9%) were identified as monogenic. We identified 1 patient with RELA, 2 with TNFAIP3, 1 with CTLA4, 1 with SLCO2A1, 4 with XIAP, 3 with IL10RA, 1 with HPS1, 1 with FOXP3, and 1 with CYBB gene mutations. We also identified 1 patient with NFKB2 and 1 with TERT mutations from the gene panel for primary immunodeficiency syndromes. The patient with refractory diarrhea caused by heterozygous truncated RelA protein expression is the first case identified worldwide, and functional analysis revealed that the mutation affected nuclear factor kappa B signaling. Genotypes were significantly associated with the clinical and pathological findings in each patient.
We identified variable monogenic diseases in the patients and found that genes responsible for primary immunodeficiency diseases were frequently involved in molecular pathogenesis. Comprehensive genetic analysis was useful for accurate molecular diagnosis, understanding of underlying pathogenesis, and selecting the optimal treatment for patients with early-onset refractory diarrhea.An infographic for this article is available at: http://links.lww.com/MPG/B853.
早发性难治性腹泻的病因包括与极早发性炎症性肠病相关的渗出性腹泻、渗透性或分泌性腹泻以及蛋白丢失性肠病。这些疾病中包括单基因疾病,但尚未全面建立综合的遗传分析。
我们建立了涵盖所有早发性腹泻相关基因的靶向基因panel。本研究共纳入了来自 15 个机构的 108 名患者。我们从所有患者中收集临床数据。对 73 名渗出性腹泻患者、4 名渗透性或分泌性腹泻患者和 8 名蛋白丢失性肠病患者进行了基因分析。
总共 108 名入组患者中有 15 名(13.9%)被确定为单基因疾病。我们鉴定出 1 名患者携带 RELA 基因突变、2 名患者携带 TNFAIP3 基因突变、1 名患者携带 CTLA4 基因突变、1 名患者携带 SLCO2A1 基因突变、4 名患者携带 XIAP 基因突变、3 名患者携带 IL10RA 基因突变、1 名患者携带 HPS1 基因突变、1 名患者携带 FOXP3 基因突变和 1 名患者携带 CYBB 基因突变。我们还从原发性免疫缺陷综合征基因panel 中鉴定出 1 名携带 NFKB2 基因突变和 1 名携带 TERT 基因突变的患者。携带异源截断 RelA 蛋白表达的难治性腹泻患者是全球首例,功能分析显示该突变影响核因子 kappa B 信号。基因型与每位患者的临床和病理发现显著相关。
我们在患者中鉴定出不同的单基因疾病,并发现原发性免疫缺陷疾病相关基因经常参与分子发病机制。全面的遗传分析有助于对早发性难治性腹泻患者进行准确的分子诊断、了解潜在的发病机制并选择最佳治疗方案。本文的图表可在以下网址获取:http://links.lww.com/MPG/B853。